[ad_1] SAN DIEGO, Nov. 5, 2024 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced today that Zev Wainberg, MD, an internationally renowned […]
Tag: Phanes Therapeutics
Phanes Therapeutics’ PT217 receives Orphan Drug Designation for Neuroendocrine Carcinoma from the FDA
[ad_1] SAN DIEGO, Aug. 16, 2024 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced today that the U.S. Food and Drug Administration […]












